EFFICACY OF INTRAVENOUS IMMUNOGLOBULINS IN RH INCOMPATIBLE NEONATES
DOI:
https://doi.org/10.33279/jkcd.v13i2.27Abstract
BACKGROUND
This hemolytic disease of fetus and newborn is a condition in which there is immunologic hemolysis of fetal / neonatal red blood cells.
OBJECTIVE:
To compare the efficacy of intravenous immunoglobulins in reducing the need for exchange transfusion in Rh incompatible neonates.
MATERIALS AND METHOD:
This Randomized Controlled Trial was conducted from 1st September 2021 to 31st August 2022 at Department of Pediatric Medicine, Khyber Teaching Hospital, Peshawar. A total of 92 Rh incompatible neonates having bilirubin more than 8mg/dl were included in the study. Randomization was performed through lottery method. All neonates received conventional intensive phototherapy given by air shield and Ohmeda lamps with white light having an intensity of 22 μW/cm/nm plus blue light of 32 μW/cm/nm. Extra fluids (10 mL per kg) was administered during the phototherapy session. Subjects in group A received conventional intensive phototherapy and IVIG single dose(1 gm/kg). In group B saline was given instead of IVIG. A change in bilirubin of 1mg was considered effective after 4 hours of starting treatment. Data was recorded for efficacy.
RESULTS:
Mean age of Group A was 15.369± 4.98 days in Group A while 17.782± 3.31 days in Group B. Mean gestational age at birth was 37.608±1.58 weeks in Group A and 38.173±1.71 weeks in Group B. Mean parity was 3.534±0.28 in Group A and 3.387±0.36 in Group B. Mean hospital stay in group A was 3.2±1.5days while 5.7±1.2 days in group B. In group A, efficacy was seen in 38 (82.6%) patients as compare to 26 (56.5%) patients in group B, resulting in significant reduction of exchange transfusions, duration of phototherapy session and hospital stay (P=0.006).
CONCLUSION:
It is concluded that a IVIG administration in patients having significant hyperbilirubinemia of Rh incompatible neonates caused reduction in requirement for exchange transfusion ,decreased hospital and time duration of phototherapy treatment thus an effective and safe treatment
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 IZHAR MUHAMMAD, HUSNA KHAN, SANA PERVEZ, TANVEER AHMAD

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.




